Characterization and distribution of drug resistance associated β-lactamase, membrane porin and efflux pump genes in MDR A. baumannii isolated from Zhenjiang, China

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 9, 2015, Pages 15393-15402

  Yang, Huijian ^a   Huang, Lan ^a   Barnie, Prince Amoah ^a   Su, Zhaoliang ^a   Mi, Zuhuang ^b   Chen, Jianguo ^c   Aparna, Vasudevan ^a   Kumar, Dinesh ^a   Xu, Huaxi ^a  

^a JIANGSU UNIVERSITY   (China)

^b Wuxi Clone Gen Tech Institute   (China)

^c First People's Hospital of Zhenjiang   (China)

Author keywords

A. baumannii; Efflux pump; Membrane porin; Multidrug resistant; lactamase

Indexed keywords

AMIKACIN; BETA LACTAMASE; BETA LACTAMASE CTX M; BETA LACTAMASE TEM 1; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORINASE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LATAMOXEF; MESSENGER RNA; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; PORIN; RNA 16S; SULFAMETHOXAZOLE; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ADEB GENE; ADER GENE; ADES GENE; ANTIBIOTIC SENSITIVITY; ARTICLE; BETA LACTAMASE GENE; CARO GENE; CHINA; GENE; GENE MUTATION; GENE OVEREXPRESSION; MULTIDRUG RESISTANT ACINETOBACTER BAUMANNII; NONHUMAN; OPRD GENE; POINT MUTATION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84946600931     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Richmond GE, Chua KL and Piddock LJ. Efflux in Acinetobacter baumannii can be determined by measuring accumulation of H33342 (bis-benzamide). J Antimicrob Chemother 2013; 68: 1594-1600.
2. Morfin-Otero R, Alcántar-Curiel MD, Rocha MJ, Alpuche-Aranda CM, Santos-Preciado JI, Gayosso-Vázquez C, Araiza-Navarro JR, Flores-Vaca M, Esparza-Ahumada S, González-Díaz E, Pérez-Gómez HR and Rodríguez-Noriega E. Acinetobacter baumannii Infections in a Tertiary Care Hospital in Mexico over the Past 13 Years. Chemotherapy 2013; 59: 57-65.
3. Chen LK, Liu YL, Hu A, Chang KC, Lin NT, Lai MJ and Tseng CC. Potential of bacteriophage [greek small letter phi] AB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii. BMC Microbiol 2013; 13: 154.
4. Lin MF, Liou ML, Tu CC, Yeh HW and Lan CY. Molecular Epidemiology of Integron-Associated Antimicrobial Gene Cassettes in the Clinical Isolates of Acinetobacter baumannii from Northern Taiwan. Ann Lab Med 2013; 33: 242-247.
5. Peymani A, Farajnia S, Nahaei MR, Sohrabi N, Abbasi L, Ansarin K and Azhari F. Prevalence of class 1 integron among multidrug-resistant Acinetobacter baumannii in Tabriz, northwest of Iran. Pol J Microbiol 2012; 61: 57-60.
6. Higgins PG, Wisplinghoff H, Stefanik D and Seifert H. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. J Antimicrob Chemother 2004; 54: 821-823.
7. Levin AS. Multiresistant Acinetobacter infections: A role for sulbactam combinations in overcoming an emerging worldwide problemc.Clin Microbiol Infect 2002; 8: 144-153.
8. Marchand I, Damier-Piolle L,Courvalin P and Lambert T. Expression of the RND-type dfflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother 2004; 48: 3298-3304.
9. Bush K. The ABCD's of beta-lactamase nomenclature. J Infect Chemother 2013; 19: 549-559.
10. Zavascki AP, Carvalhaes CG, Picão RC and Gales AC. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther 2010; 8: 71-93.
11. Hujer KM, Hamza NS, Hujer AM, Perez F, Helfand MS, Bethel CR, Thomson JM, Anderson VE, Barlow M, Rice LB, Tenover FC and Bonomo RA. Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes. Antimicrob Agents Chemother 2005; 49: 2941-2948.
12. Héritier C, Poirel L and Nordmann P. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect 2006; 12: 123-130.
13. Rezaee MA, Pajand O, Nahaei MR, Mahdian R, Aghazadeh M, Ghojazadeh M and Hojabri Z. Prevalence of Ambler class A beta-lactamases and ampC expression in cephalosporin-resistant isolates of Acinetobacter baumannii. Diagn Microbiol Infect Dis 2013; 76: 330-334.
14. Hamidian M and Hall RM. ISAba1 targets a specific position upstream of the intrinsic ampC gene of Acinetobacter baumannii leading to cephalosporin resistance. J Antimicrob Chemother 2013; 68: 2682-2683.
15. Hamidian M, Hancock D and Pand RM. Hall, Horizontal transfer of an ISAba125-activated ampC gene between Acinetobacter baumannii strains leading to cephalosporin resistance. J Antimicrob Chemother 2013; 68: 244-245.
16. Dijkshoorn L, Nemec A and Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5: 939-51.
17. Krizova L, Poirel L, Nordmann P and Nemec A. TEM-1 beta-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii. J Antimicrob Che-mother 2013; 68: 2786-2791.
18. Copur Cicek A, Saral A, Ozad Duzgun A, Yasar E, Cizmeci Z, Ozlem Balci P, Sari F, Firat M, Altintop YA, Ak S, Caliskan A, Yildiz N, Sancaktar M, Esra Budak E, Erturk A, Birol Ozgumus O and Sandalli C. Nationwide study of Escherichia coli producing extended-spectrum beta-lactamases TEM, SHV and CTX-M in Turkey. J Antibiot (Tokyo) 2013; 66: 647-650.
19. Clímaco EC, Oliveira ML, Pitondo-Silva A, Oliveira MG, Medeiros M, Lincopan N and da Costa Darini AL. Clonal complexes 104, 109 and 113 playing a major role in the dissemination of OXA-Carbapenemase-Producing Acine-tobacter baumannii in Southeast Brazil. Infect Genet Evol 2013; 19: 127-133.
20. Zander E, Higgins PG, Fernández-González A and Seifert H. Detection of intrinsic blaOXA-51-like by multiplex PCR on its own is not reliable for the identification of Acinetobacter baumannii. Int J Med Microbiol 2013; 303: 88-89.
21. Pagano M, Martins AF, Machado AB, Barin J and Barth AL. Carbapenem-susceptible Acinetobacter baumannii carrying the ISAba1 upstream blaOXA-51-like gene in Porto Alegre, southern Brazil. Epidemiol Infect 2012; 141: 330-333.
22. Tada T, Miyoshi-Akiyama T, Shimada K, Shimojima M and Kirikae T. IMP-43 and IMP- 44 Metallo beta-Lactamases with Increased Carbapenemase Activities in Multidrug-Resistant Pseudomonas aeruginosa. Anti-microb Agents Chemother 2013; 57: 4427-4432.
23. Magnet S, Courvalin P and Lambert T. Resistance-nodulation cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother 2001; 45: 3375-3380.
24. Wieczorek P, Sacha P, Hauschild T, Zórawski M, Krawczyk M and Tryniszewska E. Multidrug resistant Acinetobacterbaumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics. Folia Histochem Cytobiol 2008; 46: 257-267.
25. Ruzin A, Keeney D, Bradford PA. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. JAC 2007; 59: 1001-1004.
26. Chu YW, Chau SL and Houang ET. Presence of active efflux systems AdeABC, AdeDE and AdeXYZ in different Acinetobacter genomic DNA groups. J Med Microbiol 2006; 55: 477-478.
27. Higgins PG, Wisplinghoff H, Stefanik D and Seifert H. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. J AOAC 2004; 54: 821-823.
28. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN and Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51: 3471-3484.
29. Villalón P, Valdezate S, Cabezas T, Ortega M, Garrido N, Vindel A, Medina-Pascual MJ and Saez-Nieto JA. Endemic and epidemic Acinetobacter baumannii clones: a twelve-year study in a tertiary care hospital. BMC Microbiol 2015; 15: 47.
30. Dexter C, Murray GL, Paulsen IT and Peleg AY. Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis. Expert Rev Anti Infect Ther 2015; 13: 567-573.